Libtayo

Product
Active substances: cemiplimab. Therapeutic area: Carcinoma, Squamous Cell. ATC code: L01XC33
Reason
Quality defect
Classification
Class I
Category
drug recall
Country
European Union
Agency
EMA-DHPC
Recall date
2025-11-10
Status
Ongoing
Distribution
European Union

Official recall notice from EMA-DHPC

Recall details on Nibble Recalls: https://trynibble.app/recalls/77a122a9-80a8-40b0-a349-574e30e5beff